Detalhe da pesquisa
1.
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Haematologica
; 109(1): 72-83, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470150
2.
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Ann Hematol
; 102(2): 323-328, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576532
3.
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
; 133(10): 1140-1151, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610028
4.
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Blood
; 132(16): 1703-1713, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190321
5.
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
Am J Hematol
; 96(6): E207-E210, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725366
6.
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.
Br J Haematol
; 188(3): e11-e15, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31681986
7.
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML.
Cancers (Basel)
; 15(15)2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568726
8.
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.
Leukemia
; 35(5): 1301-1316, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948843
9.
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.
Blood Adv
; 5(9): 2294-2304, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929500